Zobrazeno 1 - 10
of 182
pro vyhledávání: '"Jia‐Fong Jhang"'
Publikováno v:
Tzu-Chi Medical Journal, Vol 36, Iss 2, Pp 110-119 (2024)
A precision diagnosis of lower urinary tract dysfunctions (LUTD) such as bladder outlet obstruction, detrusor overactivity (DO), interstitial cystitis/bladder pain syndrome (IC/BPS), dysfunctional voiding (DV), or detrusor underactivity (DU) needs in
Externí odkaz:
https://doaj.org/article/df49747feaef44b19e625f063619b073
Publikováno v:
Tzu-Chi Medical Journal, Vol 36, Iss 1, Pp 30-37 (2024)
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic inflammatory bladder disease of unknown etiology, characterized by bladder pain and frequency urgency symptoms. Based on the cystoscopic findings after hydrodistention under anesthesia
Externí odkaz:
https://doaj.org/article/006f47bf2f9e475d97948e7fe7e4e09c
Publikováno v:
Biomedicines, Vol 12, Iss 9, p 2051 (2024)
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic and debilitating condition characterized by symptoms such as bladder pain, frequent urination, and nocturia. Pain is typically perceived in the lower abdomen, pelvic floor, or urethra,
Externí odkaz:
https://doaj.org/article/b43fc756e8ae408f987dfed573c48fb6
Autor:
Lin-Nei Hsu, Jia-Fong Jhang, Yin-Chien Ou, Yao-Chi Chuang, Mei-Yu Jang, Cheih-Wen Chin, Yung-Shun Juan, Min-Hsin Yang, Wei-Yu Lin, Hsin-Ho Liu, Jian-Ri Li, Hann-Chorng Kuo
Publikováno v:
Urological Science, Vol 34, Iss 4, Pp 170-175 (2023)
Urological complications are common in patients with chronic spinal cord injury (SCI). Inappropriate bladder management may result in high voiding pressure, low bladder compliance, large postvoid residual urine volume, and recurrent urinary tract inf
Externí odkaz:
https://doaj.org/article/923182c0259944bb9081362a247923d2
Publikováno v:
Tzu-Chi Medical Journal, Vol 35, Iss 3, Pp 205-212 (2023)
Ketamine is illegally used as a recreational drug in many Asian countries. Long-term ketamine abusers often develop irritable bladder symptoms that gradually develop into more severe urinary frequency and urgency and eventually into a painful ulcerat
Externí odkaz:
https://doaj.org/article/24da4194965c40ebb0d7cd92ed6f1690
Publikováno v:
Tzu-Chi Medical Journal, Vol 35, Iss 1, Pp 31-37 (2023)
Botulinum toxin A (BoNT-A) has been widely used in several urological functional disorders including neurogenic detrusor overactivity (NDO), overactive bladder (OAB), lower urinary tract dysfunction, and interstitial cystitis/bladder pain syndrome (I
Externí odkaz:
https://doaj.org/article/b1c35ab2d0e340ef80845ad210c31adf
Publikováno v:
Toxins, Vol 16, Iss 3, p 123 (2024)
Purpose: Neurogenic lower urinary tract dysfunction (NLUTD) is common in patients with neurological lesions in the central nervous system (CNS). Medical treatment usually cannot adequately relieve NLUTD. This study reported the real-life treatment ou
Externí odkaz:
https://doaj.org/article/a78199d28e13408bb6c94f03d4a4d4b9
Publikováno v:
Biomedicines, Vol 12, Iss 3, p 522 (2024)
Our previous study showed that the Epstein–Barr virus (EBV) may be the etiology for some patients with interstitial cystitis/bladder pain syndrome (IC/BPS); hence, the current study aimed to investigate the urinary viral spectrum in patients with I
Externí odkaz:
https://doaj.org/article/c35fd6c68a6d4f78ac5f40938de3c596
Autor:
Yuan-Hong Jiang, Yu-Shu Liu, Yu-Chung Wei, Jia-Fong Jhang, Hann-Chorng Kuo, Hsin-Hui Huang, Michael W. Y. Chan, Guan-Ling Lin, Wen-Chi Cheng, Shu-Chuan Lin, Hung-Jung Wang
Publikováno v:
Diagnostics, Vol 14, Iss 5, p 468 (2024)
Bladder cancer (BCa) is a significant health issue and poses a healthcare burden on patients, highlighting the importance of an effective detection method. Here, we developed a urine DNA methylation diagnostic panel for distinguishing between BCa and
Externí odkaz:
https://doaj.org/article/f2e49546d01a4774b53ea3015fda9dd4
Publikováno v:
Toxins, Vol 16, Iss 2, p 74 (2024)
Intravesical botulinum toxin A (BoNT-A) injections are included in the interstitial cystitis/bladder pain syndrome (IC/BPS) treatment guidelines. However, the IC phenotype suitable for treatment with BoNT-A has not been clarified. Therefore, we ident
Externí odkaz:
https://doaj.org/article/5396ccd69fd9418cb1d86ad85f0d0716